Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2
- PMID: 19799852
- DOI: 10.1016/j.abb.2009.09.015
Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2
Abstract
The liver gluconeogenic pathway is recognized as a target for treating diabetes mellitus. In this study, we attempted to establish a new method to evaluate gluconeogenesis using rat H4IIE hepatoma cells. High-density preculture and exposure to hypertonic solutions, which are known to upregulate the expression of gluconeogenic genes, enhanced glucose release (GR) promoted by gluconeogenic substrates (GS: 1mM pyruvate and 10mM lactate). Our method was also applicable to the human hepatoma HepG2 cells. Measurement of glycogen content in HepG2 cells revealed that GR was compensated by glycogenolysis in the basal state and was generated by gluconeogenesis in the presence of GS. The optimized conditions increased the expression of gluconeogenic genes in HepG2 cells. Insulin and metformin dose-dependently inhibited GR and 8-(4-chlorophenylthio)-cAMP (CPT-cAMP) increased it. These results suggest that the present method is useful to evaluate the effects of nutrients, hormones and hypoglycemic agents on hepatic gluconeogenesis.
Similar articles
-
Application of (13)C-filtered (1)H NMR to evaluate drug action on gluconeogenesis and glycogenolysis simultaneously in isolated rat hepatocytes.NMR Biomed. 2002 Aug;15(5):313-9. doi: 10.1002/nbm.773. NMR Biomed. 2002. PMID: 12203222
-
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7. doi: 10.1016/j.ejphar.2009.09.003. Epub 2009 Sep 15. Eur J Pharmacol. 2009. PMID: 19765581
-
Adiponectin represses gluconeogenesis independent of insulin in hepatocytes.Biochem Biophys Res Commun. 2005 Dec 16;338(2):793-9. doi: 10.1016/j.bbrc.2005.10.007. Epub 2005 Oct 11. Biochem Biophys Res Commun. 2005. PMID: 16236252
-
Molecular action of metformin in hepatocytes: an updated insight.Curr Diabetes Rev. 2015;11(3):175-81. doi: 10.2174/1573399811666150325233108. Curr Diabetes Rev. 2015. PMID: 25808533 Review.
-
Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant?Diabetes Metab Res Rev. 2008 Sep;24(6):438-58. doi: 10.1002/dmrr.863. Diabetes Metab Res Rev. 2008. PMID: 18561209 Review.
Cited by
-
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances.Pharmaceuticals (Basel). 2024 Feb 9;17(2):229. doi: 10.3390/ph17020229. Pharmaceuticals (Basel). 2024. PMID: 38399444 Free PMC article.
-
Maternal Exercise and Paternal Exercise Induce Distinct Metabolite Signatures in Offspring Tissues.Diabetes. 2022 Oct 1;71(10):2094-2105. doi: 10.2337/db22-0341. Diabetes. 2022. PMID: 35838316 Free PMC article.
-
Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays.Cells. 2021 Nov 24;10(12):3280. doi: 10.3390/cells10123280. Cells. 2021. PMID: 34943788 Free PMC article.
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production.Nat Commun. 2021 Aug 20;12(1):5068. doi: 10.1038/s41467-021-25390-0. Nat Commun. 2021. PMID: 34417460 Free PMC article.
-
Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model.Mar Drugs. 2021 Jun 23;19(7):360. doi: 10.3390/md19070360. Mar Drugs. 2021. PMID: 34201848 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
